What question did this study set out to answer?

This research aims to identify small molecules that target the immune checkpoint TIGIT, potentially offering new cancer therapies.

May 27, 2026Open Access

Discovery of TIGIT-Targeted Small Molecules as Cancer Therapies

Key Points

This research aims to identify small molecules that target the immune checkpoint TIGIT, potentially offering new cancer therapies.
Employed machine learning to identify potential binding sites on TIGIT.
Conducted pharmacophore tests to evaluate binding requirements for inhibitors.
Identified several small molecules that effectively bind to TIGIT.
Demonstrated the potential of these inhibitors in modulating immune responses against cancer.

Abstract

This paper will discuss the results of experiments done on the immune checkpoint TIGIT and the discovery of potential immune checkpoint inhibitors that can bind to it. First, machine learning was used to find potential binding spots on TIGIT and the requirements it needs to bind. Next came the pharmacophore test

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Yuxuan Liu (Thu,) studied this question.

synapsesocial.com/papers/6a16898b0c924ddd1bd58385 https://doi.org/https://doi.org/10.29013/esr-26-3.4-3-18

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI에게 질문

Bookmark

View Full Paper